Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. (Q50951248)

25 March 2018

title

Cross-sectional study of quality of life and symptoms in chronic renal disease patients: the Modification of Diet in Renal Disease Study. (English)

1 reference

25 March 2018

0 references

1 reference

chronic renal disease

1 reference

Rocco MV

1

1 reference

25 March 2018

Gassman JJ

series ordinal

2

1 reference

25 March 2018

Wang SR

series ordinal

3

1 reference

25 March 2018

Kaplan RM

series ordinal

4

1 reference

25 March 2018

publication date

1 June 1997

1 reference

25 March 2018

American Journal of Kidney Diseases

published in

1 reference

25 March 2018

volume

29

1 reference

25 March 2018

issue

6

1 reference

25 March 2018

page(s)

888-896

1 reference

25 March 2018

Dialysis patients and patterns of symptom report on the Symptom Checklist-90-R

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Independence in activities of daily living for end-stage renal disease patients: biomedical and demographic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Functional status and personality in patients on chronic dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The functional status of ESRD patients as measured by the Sickness Impact Profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Development of a health questionnaire specific for end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Quality of life in end-stage renal disease: a reexamination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Quality-of-life issues for end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The quality of life of patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Clinical correlates of functional status in patients with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Classifying function for health outcome and quality-of-life evaluation. Self- versus interviewer modes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

A method for estimating nitrogen intake of patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Outcome measurement in kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Comparison of Quality of Well-Being scale and Functional Status Index in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Quality of life assessment for cost/utility studies in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

A comparison of health-related quality-of-life measures for rheumatoid arthritis research. The Auranofin Cooperating Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The quality of well-being in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Comparing the performance of health status measures for healthy older adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Psychologic differences between high-, normal-, and low-renin hypertensives

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Psychologic characteristics of polio survivors: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Value of recent psychological symptoms in identifying patients with esophageal contraction abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

Cost Effectiveness Analysis Applied to the Treatment of Chronic Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990463-7

7 January 2021

10.1016/S0272-6386(97)90463-7

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9186075

1 reference

25 March 2018